Table III.
Intrinsic factors of research studies affecting clinical decision-making
| Item asked | Number (%) of 327 respondents |
|---|---|
| The results of the following study designs have the potential to influence a change in my clinical practice (select all that apply to you) | |
| Meta-analysis | 244 (75) |
| Systematic review | 215 (66) |
| Randomised controlled trial | 307 (94) |
| Cohort study | 149 (46) |
| Case-control study | 155 (47) |
| Cross-sectional study | 71 (22) |
| Case series | 105 (32) |
| Case report | 54 (17) |
| Narrative review | 46 (14) |
| Editorial | 66 (20) |
| For a study to influence my clinical practice it would require a sample size of (select all that apply to you) | |
| 1 to 10 | 25 (7.7) |
| 11 to 50 | 52 (16) |
| 51 to 100 | 142 (43) |
| 101 to 500 | 190 (58) |
| 501 to 1000 | 138 (42) |
| > 1001 | 118 (36) |
| For a study to influence my clinical practice the results should report (select all that apply to you) | |
| p-value | 235 (72) |
| 95% confidence interval | 221 (68) |
| Relative risk reduction | 107 (33) |
| Absolute risk reduction | 79 (24) |
| Odds ratio | 86 (26) |
| Number needed to treat | 120 (37) |
| Mean difference | 42 (13) |
| Minimally important difference | 75 (23) |
| Sensitivity analysis | 83 (25) |
| Adjusted analysis | 41 (13) |
| None of the above | 41 (13) |
| The study designs that have had the most profound impact on my practice in the last five years are (select all that apply to you) | |
| Meta-analysis | 192 (59) |
| Systematic review | 166 (51) |
| Randomised controlled trial | 270 (83) |
| Cohort study | 58 (18) |
| Case-control study | 78 (24) |
| Cross-sectional study | 24 (7.3) |
| Case series | 46 (14) |
| Case report | 16 (4.9) |
| Narrative review | 17 (5.2) |
| Editorial | 21 (6.4) |